Examination of Low ERBB2 Protein Expression in Breast Cancer TissueAileen I. Fernandez, David L. Rimm, Matthew Liu et al.|JAMA Oncology|2022Cited by 347
Multi-institutional Assessment of Pathologist Scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Modern Pathology|2023Cited by 98
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025Nadeem R. Abu‐Rustum, Vaishnavi Sambandam, Peter J. Frederick et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 39
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyNadeem R. Abu‐Rustum, Vaishnavi Sambandam, Susana M. Campos et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 11
Multi-institutional Assessment of Pathologist scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Research Square|2022Cited by 7